BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Leases (Tables)

Leases (Tables)

3 Months Ended

Mar. 31, 2022

Information related to the Company’s right-of-use assets and related liabilities were as follows (in thousands):


	Three Months Ended
	March 31,
	2022			2021
Cash paid for operating lease liabilities	$	66		$	66
Right-of-use assets obtained in exchange for new operating lease obligations	$	444		$	1,890
Weighted-average remaining lease term	3.4 years			4.5 years
Weighted-average discount rate		12.3	%		12.3	%

Schedule of Maturities of Lease Liabilities

Maturities of lease liabilities as of March 31, 2022 for leases that have commenced are as follows (in thousands):


	March 31,
Remainder of 2022	$	774
2023		784
2024		724
2025		429
2026 and thereafter		—
Total future minimum lease obligations		2,711
Less imputed interest		(517	)
Total lease liabilities	$	2,194

Current operating lease liabilities, included in accrued liabilities	$	532
Non current lease liabilities		1,662
Total lease liabilities	$	2,194

Future minimum rental commitments under lease agreements with non-cancelable Operating Leases

Future minimum rental commitments under lease agreements, as of March 31, 2022, with non-cancelable terms greater than one year for each of the years ending December 31 are as follows (in thousands):


	Year Ended
	December 31,
Remainder of 2022	$	577
2023		786
2024		775
2025		573
2026 and thereafter		—
Total future minimum lease obligations		2,711
Less imputed interest		(517	)
Total lease liabilities	$	2,194